FDA clears Ensoma’s application for rare genetic disorder treatment

The FDA has cleared the IND for Ensoma's EN-374, targeting X-linked chronic granulomatous disease (X-CGD), a rare genetic disorder.

May 14, 2025 - 06:00
FDA clears Ensoma’s application for rare genetic disorder treatment
The FDA has cleared the IND for Ensoma's EN-374, targeting X-linked chronic granulomatous disease (X-CGD), a rare genetic disorder.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow